Substance use disorders on the rise for survivors of specific cancers

by Elana GotkineThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 inJAMA Oncology.Kati

Updated on: March 05,2024 16

Substance use disorders on the rise for survivors of specific cancers

by Elana GotkineThe prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 inJAMA Oncology.Kati

Updated on:March 05,2024 16

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on: January 22,2024 20

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on:January 22,2024 20

Financial toxicity from breast cancer treatment is common

by Lori SolomonWorldwide, breast cancer treatment is associated with substantial financial toxicity, according to a systematic review and meta-analysis published online Feb. 8 inJAMA Network Ope

Updated on: January 03,2024 9

Financial toxicity from breast cancer treatment is common

by Lori SolomonWorldwide, breast cancer treatment is associated with substantial financial toxicity, according to a systematic review and meta-analysis published online Feb. 8 inJAMA Network Ope

Updated on:January 03,2024 9

Lab-grown tumors predict treatment outcomes in landmark study

by Walter and Eliza Hall InstituteA 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell toget

Updated on: March 05,2024 10

Lab-grown tumors predict treatment outcomes in landmark study

by Walter and Eliza Hall InstituteA 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell toget

Updated on:March 05,2024 10

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on: January 22,2024 12

How the tumor microenvironment stimulates pancreatic cancer growth and progression

by Nancy Fliesler,Children's Hospital BostonMyeloid-specific deletion of LRP1 inhibits tumor growth by preventing the repression of Tsp-1. A Plot of percentage of LRP1 + multiple myeloid and

Updated on:January 22,2024 12

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on: April 01,2024 13

Routine screening for pancreatic cancer not warranted, expert panel says

(HealthDay)—There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts.Looking over

Updated on:April 01,2024 13

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Updated on: May 27,2024 5

Team develops test to predict immunotherapy response in kidney cancer

by UT Southwestern Medical CenterLeft, illuminated tumor by iPET expressing immunotherapy target, compared to control tumor (right). Credit: UTSWA novel imaging test shows promise for identifying

Updated on:May 27,2024 5

These common antibiotics could increase colon cancer risk

by Najja ParkerCancer cell during cell division. Credit: National Institutes of HealthAlthough antibiotics can help kill harmful bacteria, the drugs may increase your risk for cancer, according to a n

Updated on: April 18,2024 19

These common antibiotics could increase colon cancer risk

by Najja ParkerCancer cell during cell division. Credit: National Institutes of HealthAlthough antibiotics can help kill harmful bacteria, the drugs may increase your risk for cancer, according to a n

Updated on:April 18,2024 19

Vitamin A derivative selectively kills liver cancer stem cells

by RIKENRetinol or Vitamin A 3D space model (balls model). Credit: YassineMrabet, Wikipedia.Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurren

Updated on: March 06,2024 16

Vitamin A derivative selectively kills liver cancer stem cells

by RIKENRetinol or Vitamin A 3D space model (balls model). Credit: YassineMrabet, Wikipedia.Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurren

Updated on:March 06,2024 16

Strong family history of prostate cancer linked to better survival

byInstitute of Cancer ResearchAll-cause mortality among PrCa patients, by (A) the number of affected relatives and (B) degree of FH of the affected relatives. Deg.=degree; FH=&

Updated on: January 02,2024 9

Strong family history of prostate cancer linked to better survival

byInstitute of Cancer ResearchAll-cause mortality among PrCa patients, by (A) the number of affected relatives and (B) degree of FH of the affected relatives. Deg.=degree; FH=&

Updated on:January 02,2024 9

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on: March 30,2024 0

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on:March 30,2024 0

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on: February 01,2024 12

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on:February 01,2024 12